Sign Up to like & get recommendations! 0
Published in 2019 at "JAMA Cardiology"
DOI: 10.1001/jamacardio.2018.4566
Abstract: Importance In the Canakinumab Anti-inflammatory Thrombosis Outcome Study (CANTOS) trial, the anti-inflammatory monoclonal antibody canakinumab significantly reduced the risk of recurrent cardiovascular events in patients with previous myocardial infarction (MI) and high-sensitivity C-reactive protein (hs-CRP)… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2022.3627
Abstract: Importance Studies have demonstrated an association between single measures of high-sensitivity troponin (hsTn) and future cardiovascular events in patients with chronic coronary syndromes. However, limited data exist regarding the association between changes in serial values… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2018.1079
Abstract: Key Points Question What are the risk factors associated with major cardiovascular events within 1 year among patients who survive an acute myocardial infarction? Findings In this cohort study of 4227 patients with acute myocardial… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2021.36802
Abstract: This cohort study uses registry data from Denmark to evaluate the association between discontinuation of long-term statin treatment and major adverse cardiovascular events among individuals aged 75 years or older. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.34215
Abstract: Key Points Question What is the risk of major adverse cardiovascular events (MACEs) among patients with a prior intracerebral hemorrhage compared with the general population? Findings In this cohort study, 8991 patients with a prior… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.6952
Abstract: This cohort study investigates the association of aspirin use with risk of cardiovascular events among adults with hypertension and controlled systolic blood pressure. read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Clinical Cardiology"
DOI: 10.1002/clc.23344
Abstract: There is a paucity of contemporary data assessing the implications of atrial fibrillation (AF) on major adverse cardiovascular events (MACE) in patients with or at high‐risk for atherosclerotic disease managed in routine practice. read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Clinical Cardiology"
DOI: 10.1002/clc.23989
Abstract: To examine the utility of fractional flow reserve by coronary computed tomography (CT) angiography (FFRCT) for predicting major adverse cardiovascular events (MACE) in patients with suspected coronary artery disease (CAD). read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Annals of Hematology"
DOI: 10.1007/s00277-021-04679-6
Abstract: Paraneoplastic hypercholesterolemia has almost exclusively been reported in patients with hepatocellular carcinoma [1] and only in one case of gastric hepatoid adenocarcinoma [2] and one case of renal adenocarcinoma [3] (Table 1). Here, we report… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Heart and Vessels"
DOI: 10.1007/s00380-019-01444-8
Abstract: Clinical predictors for later adverse cardiovascular events in patients undergoing percutaneous coronary intervention (PCI) for silent myocardial ischemia remain undetermined. We investigated clinical features leading to later adverse cardiovascular events in patients who underwent PCI… read more here.